Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
B Cell
6%
Breast Tumor
19%
Cancer Associated Fibroblast
19%
Carcinogenesis
19%
CD137
19%
Cell Activation
6%
Cell Interaction
12%
Cell Maturation
6%
Clinical Trial
39%
Combination Vaccine
6%
Cytotoxic T-Cell
19%
Degenerative Disease
19%
Disease Exacerbation
6%
Entinostat
39%
Extracellular Matrix
13%
Genetic Risk
6%
Hepatocellular Carcinoma
19%
Immune Checkpoint Inhibitor
8%
Immune Response
9%
Immunity
17%
Immunosuppressive Drug
26%
Immunosuppressive Treatment
22%
Immunotherapy
75%
Macrophage
7%
Mass Cytometry
13%
Mesothelin
7%
Multi-Omics
6%
Myeloid Cell
30%
Neoadjuvant Immunotherapy
19%
Neoplasm
45%
Nivolumab
19%
Pancreas Adenocarcinoma
100%
Pancreas Adenoma
14%
Pancreas Cancer
39%
Pancreatic Tumor Microenvironment
19%
Phosphodiesterase V
19%
Plasmacytoid Dendritic Cell
6%
Protein Aggregation
6%
RNA Sequence
11%
Serositis
9%
T Cell
30%
T Cell Activation
21%
Tadalafil
19%
Tamsulosin
24%
Tertiary Lymphoid Structure
39%
Transcriptomics
34%
Treatment Modality
6%
Tumor Imaging
6%
Tumor Immune Microenvironment
7%
Tumor Microenvironment
54%
Immunology and Microbiology
Adaptive Immune System
12%
Agonist
14%
Cancer Associated Fibroblast
39%
Cancer Cell
29%
Cell Clone
19%
Coculture
11%
Cytotoxic T-Cell
19%
Dynamics
19%
Extracellular Matrix
13%
Feces microflora
19%
Genetic Risk
19%
Germfree Mouse
19%
Immune Response
15%
Immune System
9%
Immunity
14%
Immunocompetent Cell
14%
Immunology
19%
Immunomics
9%
Immunosuppression
9%
Immunosuppressive Drug
40%
Immunotherapy
70%
Inflammation Response
9%
Intestine Flora
11%
Leukocyte
9%
Lymph Node
27%
Lymphocyte
19%
Mass Cytometry
25%
Maturation
19%
Microbiome
22%
Microflora
19%
Molecular Interaction
19%
Molecular Interaction
19%
Mouse
41%
Multi-Omics
24%
Myeloid
39%
Myeloid-Derived Suppressor Cell
19%
Neoadjuvant Immunotherapy
19%
Organoid
8%
Plasmacytoid Dendritic Cell
9%
Protein Aggregation
19%
RNA Sequence
20%
Sensitization
9%
STAT3
9%
T Cell
48%
T Cell Activation
27%
Tertiary Lymphoid Structure
39%
Transcriptomics
14%
Transfer of Learning
24%
Tumor Cell
12%
Tumor-Associated Macrophage
19%
Keyphrases
Accession number
19%
Adaptive Immunity
9%
Agent-based Model
19%
Anti-tumor Response
23%
Apologizing
9%
Bioinformatics
19%
Breast Tumor Microenvironment
19%
Cancer Cells
9%
Cancer Progression
9%
Cell Systems
19%
Chemotherapy Resistance
9%
Complex Networks
9%
Computational Methods
9%
Disease Progression
9%
Entinostat
39%
HER2+
19%
Immune Cells
9%
Immune Suppression
19%
Immune System
9%
Immunomics
9%
Last Digits
9%
Latent Space
19%
Leukocyte Trafficking
9%
Lymph Node
27%
Lymphocytes
9%
Metastatic Pancreatic Ductal Adenocarcinoma
19%
Molecular Interactions
19%
Myeloid Cells
30%
Neoadjuvant Immunotherapy
19%
Nivolumab
19%
Omics Integration
19%
Pancreatic Ductal Adenocarcinoma
47%
Pancreatic Tumor Microenvironment
19%
Phase II Clinical Trial
19%
Phosphodiesterase Type 5 Inhibitors
19%
Regret
9%
Reverse Antibiotic
19%
Spatial Data Integration
19%
Spatial Landscape
39%
Spatial multi-omics
22%
Systemic Interaction
9%
Systems Immunology
19%
Systems-based Approach
9%
Tadalafil
19%
Tertiary Lymphoid Structures
39%
Therapeutic Response
9%
Tumor
32%
Tumor Cells
9%
Tumor Microenvironment
35%
Virtual Cell
19%
